S&P BSE Sensex Index Falls 1.56% This Week to 73088.33 — Data Talk
The S&P BSE Sensex Index is down 1156.57 points or 1.56% this week to 73088.33
--Largest one-week point and percentage decline since the week ending March 15, 2024
--Down for two consecutive weeks
--Down 1159.89 points or 1.56% over the last two weeks
--Largest two-week point and percentage decline since the week ending March 22, 2024
--Today it is up 599.34 points or 0.83%
--Largest one-day point and percentage gain since Thursday, March 28, 2024
--Snaps a four-trading-day losing streak
--Off 2.60% from its record close of 75038.15 hit Wednesday, April 10, 2024
--Off 2.60% from its 52-week high of 75038.15 hit Wednesday, April 10, 2024
--Up 22.52% from its 52-week low of 59655.06 hit Friday, April 21, 2023
--Rose 22.52% from 52 weeks ago
--Off 2.60% from its 2024 closing high of 75038.15 hit Wednesday, April 10, 2024
--Up 3.86% from its 2024 closing low of 70370.55 hit Tuesday, Jan. 23, 2024
--Month-to-date it is down 0.76%
--Year-to-date it is up 848.07 points or 1.17%
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
April 19, 2024 06:39 ET (10:39 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Powell Unfazed By Sticky Inflation, but Rate Cuts Are Far Off
-
After Earnings, Is Microsoft Stock a Buy, a Sell, or Fairly Valued?
-
Best- and Worst-Performing Stocks of April 2024
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Small-Cap and Value Stocks Are Undervalued
-
Why We Expect the Job Market’s Slowdown to Renew in 2024
-
5 Undervalued Stocks to Buy to Play a Little Defense
-
10 Top-Performing Dividend Stocks of the Month
-
Marathon Petroleum Earnings: No Change to Competitive Position, but Shares Look Expensive
-
Charlie Munger and How Not to Invest
-
Look Inside Berkshire Hathaway’s Portfolio Before Its Annual Meeting
-
After Earnings, Is AT&T Stock a Buy, a Sell, or Fairly Valued?
-
Mastercard Earnings: A Stable Environment Highlights the Firm’s Strengths
-
Pfizer Earnings: Solid Results Supported by Steady Tracking Toward $4 Billion In Cost Cuts
-
Starbucks Earnings: Not a Lot to Like About Results as Global Traffic Sputters